Back to Search Start Over

Long-term expandable mouse and human-induced nephron progenitor cells enable kidney organoid maturation and modeling of plasticity and disease.

Authors :
Huang B
Zeng Z
Kim S
Fausto CC
Koppitch K
Li H
Li Z
Chen X
Guo J
Zhang CC
Ma T
Medina P
Schreiber ME
Xia MW
Vonk AC
Xiang T
Patel T
Li Y
Parvez RK
Der B
Chen JH
Liu Z
Thornton ME
Grubbs BH
Diao Y
Dou Y
Gnedeva K
Ying Q
Pastor-Soler NM
Fei T
Hallows KR
Lindström NO
McMahon AP
Li Z
Source :
Cell stem cell [Cell Stem Cell] 2024 Jun 06; Vol. 31 (6), pp. 921-939.e17. Date of Electronic Publication: 2024 Apr 30.
Publication Year :
2024

Abstract

Nephron progenitor cells (NPCs) self-renew and differentiate into nephrons, the functional units of the kidney. Here, manipulation of p38 and YAP activity allowed for long-term clonal expansion of primary mouse and human NPCs and induced NPCs (iNPCs) from human pluripotent stem cells (hPSCs). Molecular analyses demonstrated that cultured iNPCs closely resemble primary human NPCs. iNPCs generated nephron organoids with minimal off-target cell types and enhanced maturation of podocytes relative to published human kidney organoid protocols. Surprisingly, the NPC culture medium uncovered plasticity in human podocyte programs, enabling podocyte reprogramming to an NPC-like state. Scalability and ease of genome editing facilitated genome-wide CRISPR screening in NPC culture, uncovering genes associated with kidney development and disease. Further, NPC-directed modeling of autosomal-dominant polycystic kidney disease (ADPKD) identified a small-molecule inhibitor of cystogenesis. These findings highlight a broad application for the reported iNPC platform in the study of kidney development, disease, plasticity, and regeneration.<br />Competing Interests: Declaration of interests A.P.M. is a scientific advisor or consultant for Novartis, eGENESIS, Trestle Biotherapeutics, GentiBio, and IVIVA Medical. Zhongwei Li, B.H., Z.Z., A.P.M., K.R.H., and N.M.P.-S. have applied for intellectual property protection on the technologies discussed here.<br /> (Copyright © 2024 Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1875-9777
Volume :
31
Issue :
6
Database :
MEDLINE
Journal :
Cell stem cell
Publication Type :
Academic Journal
Accession number :
38692273
Full Text :
https://doi.org/10.1016/j.stem.2024.04.002